FDA approves second generic naloxone spray

Advertisements

FDA approves second generic naloxone spray
hnesich_drupal
Jun 22, 2022

The Food and Drug Administration approved the second generic naloxone nasal spray, an emergency treatment for known or suspected opioid overdose. The agency approved the first generic naloxone nasal spray in 2019.

Headline
Advertisements
Shopping Cart
Generated by Feedzy
error: Content is protected !!
Share via
Copy link
Powered by Social Snap